Page last updated: 2024-08-24

n 0437, (-)-isomer and Sleep Wake Disorders

n 0437, (-)-isomer has been researched along with Sleep Wake Disorders in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's11 (84.62)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Asakawa, T; Feng, C; Li, C; Qu, Y; Sun, W; Sun, Z; Wang, Q; Yang, T; Yang, Y1
Ayuga, Á; Gómez-Arguelles, JM; Marey, J; Moya, M; Ramírez, F; Salvador, A; Valldeoriola, F1
Albanese, M; Liguori, C; Mercuri, NB; Olivola, E; Pierantozzi, M; Stefani, A1
Ding, ZT; Fei, L; Zhou, D1
Antonini, A; Brown, RG; Friedman, JH; Ghys, L; Martinez-Martin, P; Onofrj, M; Ray Chaudhuri, K; Surmann, E; Trenkwalder, C1
Antonini, A; Calandrella, D; Koutsikos, K; Merello, M; Pilleri, M1
Boroojerdi, B; Chaudhuri, KR; Friedman, JH; Ghys, L; Moran, K; Surmann, E; Swick, TJ; Trenkwalder, C1
Bauer, L; Chung, SJ; Ikeda, J; Jeon, BS; Kim, JM; Kim, JW; Singh, P; Thierfelder, S1
Albanese, M; Imbriani, P; Liguori, C; Marciani, MG; Mercuri, NB; Pierantozzi, M; Placidi, F; Stanzione, P; Stefani, A1
Lan, DM; Wang, Y; Wu, H-; Yang, YC; Zhao, ZX1
Culebras, A; Kelly, JJ1
Boroojerdi, B; Fichtner, A; Giladi, N; Poewe, W1
Anderson, T; Boroojerdi, B; Chaudhuri, KR; Dioszeghy, P; Fine, J; Hill, D; Honczarenko, K; Kassubek, J; Kies, B; Myllyla, V; Nikl, J; Poewe, W; Rudzinska, M; Steiger, M; Surmann, E; Tolosa, E; Trenkwalder, C; Whitesides, J; Zucconi, M1

Reviews

3 review(s) available for n 0437, (-)-isomer and Sleep Wake Disorders

ArticleYear
A meta-analysis evaluating effects of the rotigotine in Parkinson's disease, focusing on sleep disturbances and activities of daily living.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:10

    Topics: Activities of Daily Living; Dopamine Agonists; Humans; Parkinson Disease; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2022
The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson's disease: a meta-analysis.
    Sleep medicine, 2019, Volume: 61

    Topics: Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome

2019
Effects of rotigotine on Parkinson's disease-related sleep disturbances.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:18

    Topics: Animals; Clinical Trials as Topic; Dopamine Agonists; Drug Evaluation, Preclinical; Humans; Parkinson Disease; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome

2013

Trials

7 trial(s) available for n 0437, (-)-isomer and Sleep Wake Disorders

ArticleYear
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
    Journal of neurology, 2019, Volume: 266, Issue:3

    Topics: Aged; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Polysomnography; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2019
Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER.
    Parkinsonism & related disorders, 2013, Volume: 19, Issue:7

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Apathy; Dopamine Agonists; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Male; Middle Aged; Mood Disorders; Parkinson Disease; Psychiatric Status Rating Scales; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2013
Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study.
    European neurology, 2014, Volume: 71, Issue:3-4

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2014
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
    BMC neurology, 2015, Feb-28, Volume: 15

    Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2015
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.
    Sleep medicine, 2016, Volume: 21

    Topics: Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Polysomnography; Severity of Illness Index; Sleep Stages; Sleep Wake Disorders; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes

2016
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:12

    Topics: Aged; Dopamine Agonists; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes

2010
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).
    Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome

2011

Other Studies

3 other study(ies) available for n 0437, (-)-isomer and Sleep Wake Disorders

ArticleYear
The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study.
    The International journal of neuroscience, 2018, Volume: 128, Issue:4

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Cognition Disorders; Dopamine Agonists; Female; Humans; Male; Parkinson Disease; Product Surveillance, Postmarketing; Retrospective Studies; Sleep Wake Disorders; Spain; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome; Urination Disorders

2018
An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson's disease.
    Sleep & breathing = Schlaf & Atmung, 2017, Volume: 21, Issue:2

    Topics: Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Polysomnography; Quality of Life; Sleep Stages; Sleep Wake Disorders; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes; Video Recording

2017
Sleep disorders and neuromuscular diseases.
    Reviews in neurological diseases, 2008,Summer, Volume: 5, Issue:3

    Topics: Administration, Cutaneous; Brain Injuries; Continuous Positive Airway Pressure; Copper; Diabetic Neuropathies; Dopamine Agonists; Humans; Ischemic Attack, Transient; Myasthenia Gravis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Restless Legs Syndrome; Sleep Apnea Syndromes; Sleep Wake Disorders; Stroke; Tetrahydronaphthalenes; Thiophenes

2008